Status:
UNKNOWN
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
Lead Sponsor:
Cairo University
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
200 women with PPH will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Ergometrine 400µgm (Methergin® Novartis, Switzerland) and group 2 will rec...
Detailed Description
Obstetric haemorrhage remains one of the major causes of maternal death in both developed and developing countries. Postpartum haemorrhage (PPH) is defined as a blood loss \>500 ml more of blood from ...
Eligibility Criteria
Inclusion
- Atonic PPH
Exclusion
- Gestational age\<37 weeks
- Hypertension, cardiac disease or preeclampsia
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02306733
Start Date
November 1 2014
Last Update
January 23 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BeniSuef University hospitals
BeniSuef, Egypt
2
Cairo university hospitals
Cairo, Egypt